CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Director bought 2,298,850 shares at $4.35 ($9,999,998)
- 4 Exercise or conversion CFO, Sec'y & Treasurer acquired 5,679 shares (option exercise)
- 4 Open-market buy Director bought 2,298,850 shares at $4.35 ($9,999,998)
- 4 Open-market buy Director bought 147,800 shares at $4.35 ($642,930)
- 4 Open-market buy Director bought 160,919 shares at $4.35 ($699,998)
- 4 Open-market buy Director bought 5,855 shares at $4.29 ($25,132)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $6.18 ($61,753)
- 4 Open-market buy Director bought 20,000 shares at $6.34 ($126,756)
- 4 Open-market buy Director bought 60,000 shares at $6.50 ($390,186)
- 4 Open-market buy Director bought 9,497 shares at $6.34 ($60,220)
- 4 Open-market buy Director bought 28,361 shares at $6.33 ($179,502)
- 4 Open-market buy Director bought 20,000 shares at $6.51 ($130,104)
- 4 Open-market buy President & CEO bought 3,000 shares at $6.46 ($19,375)
- 4 Open-market buy CFO, Sec'y & Treasurer bought 1,000 shares at $6.51 ($6,510)
- 4 Open-market buy Director bought 8,396 shares at $8.04 ($67,490)
- 4 Open-market buy Director bought 50,000 shares at $7.69 ($384,440)
- 4 Open-market buy Director bought 1,604 shares at $7.12 ($11,416)
Page 15 of 17 · 336 filings